requiring health care providers to disclose to patients indirect financial incentives received by the provider.

HB 1335 requires physicians to disclose to patients any financial incentives exceeding $5,000 received from a single source (like drug manufacturers) for preferential promotions related to specific treatments. It directly affects patients receiving care from providers who receive such payments, ensuring they learn about potential conflicts before prescriptions. The law mandates written disclosure as part of informed consent, including the source, amount, and a statement that the recommendation is based on clinical judgment. This applies only to incentives tied to the treatment being prescribed, not general practice income. The bill takes effect January 1, 2027.